China Resources Medical Holdings Company Limited (FRA:1PH)
Germany flag Germany · Delayed Price · Currency is EUR
0.3740
+0.0020 (0.54%)
At close: Sep 29, 2025

FRA:1PH Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
499642724896678911
Upgrade
Market Cap Growth
-1.78%-11.34%-19.24%32.11%-25.49%35.80%
Upgrade
Enterprise Value
631928643859682733
Upgrade
Last Close Price
0.370.460.510.640.470.62
Upgrade
PE Ratio
8.908.5722.0224.8511.7323.45
Upgrade
PS Ratio
0.450.490.560.841.102.64
Upgrade
PB Ratio
0.540.650.810.620.721.15
Upgrade
P/TBV Ratio
1.481.862.621.161.202.21
Upgrade
P/FCF Ratio
5.096.868.0116.639.5716.75
Upgrade
P/OCF Ratio
3.093.824.757.656.9011.30
Upgrade
EV/Sales Ratio
0.560.710.500.801.112.13
Upgrade
EV/EBITDA Ratio
4.665.343.577.179.3415.70
Upgrade
EV/EBIT Ratio
10.069.325.9114.0913.4121.04
Upgrade
EV/FCF Ratio
6.449.937.1215.949.6313.48
Upgrade
Debt / Equity Ratio
0.130.210.330.230.250.15
Upgrade
Debt / EBITDA Ratio
1.001.161.582.573.142.47
Upgrade
Debt / FCF Ratio
1.242.263.266.053.382.23
Upgrade
Asset Turnover
0.690.730.640.560.460.33
Upgrade
Inventory Turnover
27.5526.6524.5023.8721.4920.71
Upgrade
Quick Ratio
0.620.590.551.201.021.66
Upgrade
Current Ratio
0.740.720.661.321.141.88
Upgrade
Return on Equity (ROE)
7.02%9.26%3.71%3.75%6.46%5.13%
Upgrade
Return on Assets (ROA)
1.92%3.49%3.39%1.99%2.37%2.07%
Upgrade
Return on Capital (ROIC)
2.85%5.11%4.76%2.60%2.89%2.43%
Upgrade
Return on Capital Employed (ROCE)
4.70%8.50%10.10%3.50%5.20%4.10%
Upgrade
Earnings Yield
11.24%11.67%4.54%4.02%8.53%4.26%
Upgrade
FCF Yield
19.65%14.57%12.49%6.01%10.45%5.97%
Upgrade
Dividend Yield
4.27%3.77%1.51%0.70%2.88%1.50%
Upgrade
Payout Ratio
36.02%24.59%16.44%48.75%21.79%37.11%
Upgrade
Buyback Yield / Dilution
---0.18%0.14%-0.21%-0.50%
Upgrade
Total Shareholder Return
4.29%3.77%1.33%0.84%2.67%1.00%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.